摘要
目的:了解国内药物经济学研究的现状及质量,为规范药物经济学研究提供借鉴。方法:系统检索中国知网、万方、维普等数据库中2017年1月-2018年5月发表的药物经济学研究相关文献,利用《药物经济学评价报告质量评估指南》(简称"PEERs")进行质量评价。结果:共纳入160篇国内药物经济学研究文献。PEERs评价结果显示,符合率为32.5%(52/160),其中完全符合(即报告具有一定参考价值)占1.3%(2/160),基本符合(即报告经修改后具有一定参考价值)占31.3%(50/160),不太符合(即报告不具有参考价值)占67.5%(108/160)。国内药物经济学研究在研究对象、评价方法及内容、研究设计、研究目的及设计类型等方面质量较高;但在研究角度、增量成本/增量产出分析、敏感性分析等方面质量偏低,存在未进行说明或者阐述不清的情况。结论:国内药物经济学研究文献质量参差不齐,其研究质量还需进一步提高。建议规范药物经济学评价研究,使其结果更具科学性和客观性。
OBJECTIVE:To investigate current status and quality of domestic pharmacoeconomic literatures,and to provide reference for the standardization of pharmacoeconomic research.METHODS:Retrieved from CNKI,Wanfang,VIP and other database,the pharmacoeconomic literatures published from Jan.2017 to May 2018 were collected.The qualities of literatures were evaluated with Guidelines for Quality Evaluation of Pharmacoeconomics Evaluation Reports(“PEERs”for short).RESULTS:Totally 160 domestic pharmacoeconomic research literatures were included.The results of PEERs evaluation showed of which the coincidence rate was 32.5% (52/160).The literatureswhich were in full compliance(the report had a certain reference value)accounted for 1.3% (2/160),which were in basic compliance(the report had certain reference value after being revised)accounted for 31.3% (50/160),which were in non-conformity(the report did not had reference value)accounted for 67.5% (108/160).Domestic pharmacoeconomic researches were of high quality in terms of research object,evaluation method and content,research purpose,research design and design type,etc.;but the researches were of low quality in terms of research angle,incremental cost/incremental output analysis,sensitivity analysis and other aspects,and there was no explanation or unclear elaboration.CONCLUSIONS:The quality of domestic pharmacoeconomic research literatures are uneven,and their research quality needs to be further improved.It is recommended to standardize the evaluation of pharmacoeconomics,making the evaluation of pharmacoeconomics more scientific and objective.
作者
高海亮
姜婷婷
张聪
张梦培
张皓翔
王志恒
段利忠
朱文涛
GAO Hailiang;JIANG Tingting;ZHANG Cong;ZHANG Mengpei;ZHANG Haoxiang;WANG Zhiheng;DUANLizhong;ZHU Wentao(School of Management,Beijing University of TCM,Beijing 100029,China)
出处
《中国药房》
CAS
北大核心
2019年第10期1393-1395,共3页
China Pharmacy
基金
国家社会科学基金资助项目(No.16BJY126)
关键词
药物经济学评价报告质量评估指南
药物经济学
文献质量
评价
Guidelines for Quality Evaluation of Pharmacoeconomics Evaluation Report
Pharmacoeconomics
Literaturequality
Evaluation
